[go: up one dir, main page]

GB1326928A - Therapeutic material - Google Patents

Therapeutic material

Info

Publication number
GB1326928A
GB1326928A GB6124070A GB6124070A GB1326928A GB 1326928 A GB1326928 A GB 1326928A GB 6124070 A GB6124070 A GB 6124070A GB 6124070 A GB6124070 A GB 6124070A GB 1326928 A GB1326928 A GB 1326928A
Authority
GB
United Kingdom
Prior art keywords
therapeutic material
precipitation
liquid
subjecting
dec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6124070A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of GB1326928A publication Critical patent/GB1326928A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1326928 Therapeutic material INSTITUT PASTEUR 23 Dec 1970 [31 Dec 1969] 61240/ 70 Heading A5B A therapeutic material, capable of inhibiting the development of leukaemia and other cancers, is prepared by subjecting a cell suspension to a first precipitation with polyethyleneglycol; separating the precipitate from the liquid; subjecting the liquid to a second precipitation with silico-tungstic acid, e.g. silicoduodecitungstic acid; and separating the therapeutic material containing liquid from the precipitate. The cell suspension may comprise (i) cells of normal lymphoid tissues, (2) cultures in vitro of cells which are derived from (1), or (3) cell cultures infected with a virus of the leukaemic type. Both precipitations may be carried out at a temperature from -10 to +10‹C. From 2 to 10% by weight of polyethylene glycol may be added in the first precipitation.
GB6124070A 1969-12-31 1970-12-23 Therapeutic material Expired GB1326928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (en) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
GB1326928A true GB1326928A (en) 1973-08-15

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6124070A Expired GB1326928A (en) 1969-12-31 1970-12-23 Therapeutic material

Country Status (11)

Country Link
JP (1) JPS4940922B1 (en)
AT (1) AT301749B (en)
BE (1) BE760727A (en)
CA (1) CA956573A (en)
CH (1) CH533988A (en)
DE (1) DE2064296C2 (en)
DK (1) DK128054B (en)
FR (1) FR2073293B1 (en)
GB (1) GB1326928A (en)
LU (1) LU62332A1 (en)
NL (1) NL7019097A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027429A3 (en) * 1979-10-11 1982-05-12 Liborio Dr. Bonifacio Tumor antidote (oncoclasine) for the cure of tumors, and process for its extraction

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144731C (en) 1976-07-30 1982-10-18 Nordisk Insulinlab PROCEDURE FOR INSULATING PROTEIN HORMONES DERIVED FROM HUMAN HYPPHYPHYSE TISSUE
JPS5330639U (en) * 1976-08-20 1978-03-16
JPS5925332A (en) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd Preparation of antitumor glycoprotein
FR2568125B1 (en) * 1984-07-25 1988-04-15 Kogo Michiko ANTI-TUMOR AGENT CONTAINING SUGAR PROTEIN
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027429A3 (en) * 1979-10-11 1982-05-12 Liborio Dr. Bonifacio Tumor antidote (oncoclasine) for the cure of tumors, and process for its extraction
US4462987A (en) * 1979-10-11 1984-07-31 Liborio Bonifacio Process and composition for treating tumors in mice

Also Published As

Publication number Publication date
BE760727A (en) 1971-05-27
DE2064296A1 (en) 1971-07-15
CH533988A (en) 1973-02-28
NL7019097A (en) 1971-07-02
FR2073293A1 (en) 1971-10-01
FR2073293B1 (en) 1973-01-12
AT301749B (en) 1972-09-11
LU62332A1 (en) 1971-05-27
DK128054B (en) 1974-02-25
CA956573A (en) 1974-10-22
JPS4940922B1 (en) 1974-11-06
DE2064296C2 (en) 1984-10-25

Similar Documents

Publication Publication Date Title
Strander et al. Production of human lymphoblastoid interferon
KR900700592A (en) Soluble T-4 Derivative
GB1267136A (en)
GB1326928A (en) Therapeutic material
FR2283223A1 (en) Thio-bacteria of beggiatoaceae species - industrially grown in vitro and used in cosmetic and pharmaceutical compsns
GB1188519A (en) Method for the Purification of Lipopolysaccharides
GB1286250A (en) Heteroploid cell lines
GB1436529A (en) Process for preparing a blood fraction
GB1287602A (en) 4,6-DICHLORO-Delta<4.6>-OESTRADIENES
Hsu et al. Acinonyx jubatus (cheetah)
EG11829A (en) The introduction of (o-ch3)group to olefin in it's gases stage
ES424506A1 (en) Process for reducing sticking of blood cells to glass in blood testing procedures
ES382051A1 (en) Pharmacologically active esters and amides of n-{8 3-trifluoromethylphenyl{9 -anthranilic acid
Bhargava et al. A comparison of the ability of normal liver, a premalignant liver, a solid hepatoma and the Zajdela ascitic hepatoma, to take up amino acids in vitro
Lafferty et al. A mediator acting as a costimulator for the development of cytotoxic responses in vitro
GB1358321A (en) Method od tissue cell culture
GB1262147A (en) Antimicrobial factors
FR2285144A1 (en) N-ACYL DERIVATIVES OF ORGOTEIN, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY, AND THEIR PREPARATION PROCESS
Keutel et al. Induction of chromosomal breakage in cultured human leucocytes by luteoskyrin
GB1460163A (en) Purification of 6,7-methylene steroid lactones
GB1378103A (en) Serological reagent and test for neisseria gonorrhoeae antibodies
ES449886A1 (en) N{40 -(Aminoacylaminophenyl) acetamidines
Tsuneyoshi et al. Reinvestigations of the Spindle Body and Related Problems
GB1436323A (en) Cell and virus culture systems
GB1280569A (en) 6-aminomethyl steroids

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee